Currently, there are 89.77M common shares owned by the public and among those 89.08M shares have been available to trade.
The company’s stock has a 5-day price change of -5.41% and -19.39% over the past three months. AUB shares are trading -17.79% year to date (YTD), with the 12-month market performance down to -12.36% lower. It has a 12-month low price of $30.31 and touched a high of $44.54 over the same period. AUB has an average intraday trading volume of 1.04 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.92%, -11.71%, and -16.46% respectively.
Institutional ownership of Atlantic Union Bankshares Corp (NYSE: AUB) shares accounts for 93.64% of the company’s 89.77M shares outstanding.
It has a market capitalization of $2.81B and a beta (3y monthly) value of 0.79. The stock’s trailing 12-month PE ratio is 13.62, while the earnings-per-share (ttm) stands at $2.29. The company has a debt-to-equity ratio at 0.20. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.58% over the week and 2.84% over the month.
Analysts forecast that Atlantic Union Bankshares Corp (AUB) will achieve an EPS of 0.71 for the current quarter, 0.67 for the next quarter and 4.07 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.67 while analysts give the company a high EPS estimate of 0.67. Comparatively, EPS for the current quarter was 0.65 a year ago. Earnings per share for the fiscal year are expected to increase by 25.18%, and 18.72% over the next financial year.
Looking at the support for the AUB, a number of firms have released research notes about the stock. Hovde Group stated their Outperform rating for the stock in a research note on March 17, 2025, with the firm’s price target at $46-$40. Hovde Group coverage for the Atlantic Union Bankshares Corp (AUB) stock in a research note released on January 27, 2025 offered a Outperform rating with a price target of $46. Piper Sandler was of a view on January 13, 2025 that the stock is Overweight, while Hovde Group gave the stock Outperform rating on September 13, 2024, issuing a price target of $46- $45. Hovde Group on their part issued Outperform rating on July 26, 2024.
